Clinical trials recruiting for Thymus Neoplasms
3
Recruiting trials
1
US states with sites
6
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 1Phase 3 1Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| 177Lu-edotreotide | 1 |
| Cyclophosphamide | 1 |
| Everolimus | 1 |
| Fludarabine | 1 |
| Proton radiation | 1 |
| TNhYP218 CAR T Cells | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 1 |
Top cities
Self-screener
Recruiting trials
- Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
- Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
- Study on Proton Radiotherapy of Thymic Malignancies
Related conditions
Trials recruiting for Thymus Neoplasms often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Stomach Neoplasms 11Pancreatic Neoplasms 38Pancreatic cancer 870Ovarian Neoplasms 18Neuroendocrine Tumors 25Mesothelioma 27Lung Neuroendocrine Neoplasm 3Lung Neoplasms 33Colorectal cancer 1359
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Thymus Neoplasms trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.